This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lesokhin, A. M. Articles by Horwitz, M. S. Search for Related Content PubMed PubMed Citation Articles by Lesokhin, A. M. Articles by Horwitz, M. S.

 Previous Article  |  Next Article 

Journal of Virology, August 2002, p. 8236-8243, Vol. 76, No. 16
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.16.8236-8243.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Inhibition of Chemokine Expression by Adenovirus Early Region Three (E3) Genes

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461

Received 14 March 2002/ Accepted 12 May 2002

Adenoviruses (Ad) have a variety of immunoregulatory genes, many of which are clustered in a 3.5-kb segment of DNA known as early region 3 (E3). Ad E3 codes for proteins that downregulate surface expression of class I major histocompatibility antigens and also inhibit tumor necrosis factor alpha (TNF-)- and Fas-induced cytolysis. We were interested in determining whether chemokine production or activity might also be inhibited by Ad E3 and we have studied this function in a human astrocytoma cell line, U373. Astrocytes constitute a part of the blood-brain barrier, and chemokines (IP-10, IL-8, MCP-1-4, and MIPs) expressed by them may contribute to leukocyte infiltration within the brain during inflammation. When U373 cells are activated by the proinflammatory molecule TNF-, the increase in chemokine MCP-1, IL-8, and IP-10 transcripts is blocked by a recombinant Ad expressing the E3 genes under cytomegalovirus promoter control. Comparable Ads expressing green fluorescent protein in place of E3 have no effect on these chemokines. Ads also have been extensively studied as gene therapy vectors and most have a deletion of the E3 region to permit the insertion of larger fragments of foreign DNA. Our results suggest that construction of Ad vectors to include E3 expression cassettes will improve the efficacy and safety of such viral-based gene therapy protocols.

This article has been cited by other articles:

• Delgado-Lopez, F., Horwitz, M. S. (2006). Adenovirus RID{alpha}{beta} Complex Inhibits Lipopolysaccharide Signaling without Altering TLR4 Cell Surface Expression.. J. Virol. 80: 6378-6386 [Abstract] [Full Text]  
• Shayakhmetov, D. M., Li, Z.-Y., Ni, S., Lieber, A. (2005). Interference with the IL-1-Signaling Pathway Improves the Toxicity Profile of Systemically Applied Adenovirus Vectors. J. Immunol. 174: 7310-7319 [Abstract] [Full Text]  
• Barbu, A. R., Akusjarvi, G., Welsh, N. (2005). Adenoviral-Mediated Transduction of Human Pancreatic Islets: Importance of Adenoviral Genome for Cell Viability and Association with a Deficient Antiviral Response. Endocrinology 146: 2406-2414 [Abstract] [Full Text]  
• Fessler, S. P., Chin, Y. R., Horwitz, M. S. (2004). Inhibition of Tumor Necrosis Factor (TNF) Signal Transduction by the Adenovirus Group C RID Complex Involves Downregulation of Surface Levels of TNF Receptor 1. J. Virol. 78: 13113-13121 [Abstract] [Full Text]  
• Collins, S. E., Noyce, R. S., Mossman, K. L. (2004). Innate Cellular Response to Virus Particle Entry Requires IRF3 but Not Virus Replication. J. Virol. 78: 1706-1717 [Abstract] [Full Text]  
• Pierce, M. A., Chapman, H. D., Post, C. M., Svetlanov, A., Efrat, S., Horwitz, M., Serreze, D. V. (2003). Adenovirus Early Region 3 Antiapoptotic 10.4K, 14.5K, and 14.7K Genes Decrease the Incidence of Autoimmune Diabetes in NOD Mice. Diabetes 52: 1119-1127 [Abstract] [Full Text]